NF-κB, chemokine gene transcription and tumour growth (original) (raw)

• Rossi, D. & Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217–242 (2000).
  Article CAS PubMed Google Scholar
• Luster, A. D. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14, 129–135 (2002).
  Article CAS PubMed Google Scholar
• Homey, B., Muller, A. & Zlotnik, A. Chemokines: agents for the immunotherapy of cancer. Nature Rev. Immunol. 2, 175–184 (2002).
  Article CAS Google Scholar
• Chensue, S. W. Molecular machinations, chemokine signals in host–pathogen interactions. Clin. Microbiol. Rev. 14, 821–835 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Devalaraja, M. N. & Richmond, A. Multiple chemotactic factors, fine control or redundancy? Trends Pharmacol. Sci. 20, 151–156 (1999).
  Article CAS PubMed Google Scholar
• Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001).This article reviews the role of chemokines as regulators of tumour growth and metastasis, or the inhibition of tumour growth.
  Article CAS PubMed Google Scholar
• Strieter, R. M. Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nature Immunol. 2, 285–286 (2001).A review of opposing roles of angiogenic and angiostatic CXC-chemokines in tumour growth.
  Article CAS Google Scholar
• Payne, A. S. & Cornelius, L. A. The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol. 118, 915–922 (2002).This article reviews the roles of CXCL1, CXCL8 and CCL5 in melanoma.
  Article CAS PubMed Google Scholar
• Luan, J. et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukocyte Biol. 62, 588–597 (1997).
  Article CAS PubMed Google Scholar
• Robledo, M. M. et al. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J. Biol. Chem. 276, 45098–45105 (2001).
  Article CAS PubMed Google Scholar
• Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M. T., & Hwang, S. T. Expression of CC-chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl Cancer Inst. 93, 1638–1643 (2001).
  Article CAS PubMed Google Scholar
• Sunwoo, J. B. et al. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous-cell carcinoma. Clin. Cancer Res. 7, 1419–1428 (2001).
  CAS PubMed Google Scholar
• Dong, G. et al. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis and the NF-κB signal pathway. Cancer Res. 61, 4797–4808 (2001).
  CAS PubMed Google Scholar
• Cusack, J. C. Jr et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341, implications for systemic nuclear factor-κB inhibition. Cancer Res. 61, 3535–3540 (2001).This article shows that use of the proteasome inhibitor PS-341 to block the activation of NF-κB results in the inhibition of tumour growth when it is used in combination with the chemotherapeutic agent CPT-11.
  CAS PubMed Google Scholar
• Sprenger, H., Lloyd, A. R., Meyer, R. G., Johnston, J. A. & Kelvin, D. J. Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene. J. Immunol. 153, 2524–2532 (1994).
  CAS PubMed Google Scholar
• Bonecchi, R. et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J. Immunol. 164, 3862–3869 (2000).
  Article CAS PubMed Google Scholar
• Lloyd, A. R. et al. Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin-8 receptors on polymorphonuclear leukocytes. J. Biol. Chem. 270, 28188–28192 (1995).
  Article CAS PubMed Google Scholar
• Ivarsson, K., Ekerydh, A., Fyhr, I. M., Janson, P. O. & Brannstrom, M. Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas. Acta Obstet. Gynecol. Scand. 79, 777–784 (2000).
  CAS PubMed Google Scholar
• Li, A., Varney, M. L. & Singh, R. K. Expression of interleukin-8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin. Cancer Res. 7, 3298–3304 (2001).
  CAS PubMed Google Scholar
• Azenshtein, E. et al. The CC-chemokine RANTES in breast carcinoma progression, regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 62, 1093–1102 (2002).
  CAS PubMed Google Scholar
• Mrowietz, U. et al. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br. J. Cancer 79, 1025–1031 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Genin, P., Algarte, M., Roof, P., Lin, R. & Hiscott, J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-κB and IFN-regulatory factor transcription. J. Immunol. 164, 5352–5361 (2000).
  Article CAS PubMed Google Scholar
• Yang, J. M. & Richmond, A. Constitutive IKK activity correlates with NF-κB activation in human melanoma cells. Cancer Res. 61, 4901–4909 (2001).This article shows that melanoma cell lines have constitutive IKK activity, and also constitutive phosphorylation of p65, which results in constitutive NF-κB transcriptional activity and enhanced expression of chemokines. The article also shows that the chemokine CXCL1 contributes to the constitutive activation of IKK through an autocrine loop.
  CAS PubMed Google Scholar
• Yang, C.-R. et al. Coordinate modulation of Sp1, NF-κB and p53 in confluent human malignant melanoma cells after ionizing radiation. FASEB J. 14, 379–392 (2000).
  Article CAS PubMed Google Scholar
• Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S. & Haegeman, G. The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274, 32091–32098 (1999).
  Article CAS PubMed Google Scholar
• Huang, S., De Guzman, A., Bucana, C. D. & Fidler, I. J. Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-κB activity. Cytokines Cell. Mol. Ther. 6, 9–17 (2000).
  Article CAS PubMed Google Scholar
• Kunz, M. et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am. J. Pathol. 155, 753–763 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, S., DeGuzman, A., Bucana, C. D. & Fidler, I. J. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res. 6, 2573–2581 (2000).
  CAS PubMed Google Scholar
• Bakker, T. R., Reed, D., Renno, T. & Jongeneel, C. V. Efficient adenoviral transfer of NF-κB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int. J. Cancer 80, 320–323 (1999).
  Article CAS PubMed Google Scholar
• Wang, D. et al. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 19, 4647–4659 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Baldwin, A. S. Control of oncogenesis and cancer-therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107, 241–246 (2001).An excellent review of NF-κB, its role in cancer and the potential for therapeutic intervention using inhibitors of NF-κB.
  Article CAS PubMed PubMed Central Google Scholar
• Beg, A. A. et al. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6, 1899–1913 (1992).
  Article CAS PubMed Google Scholar
• Didonato, J., Mercurio, F. & Karin, M. Phosphorylation of IκB-α precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol. 15, 1302–1311 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• DiDonato, J. et al. Mapping of the inducible I-κB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16, 1295–1304 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Pando, M. P. & Verma, I. M. Signal-dependent and -independent degradation of free and NF-κB-bound IκB-α. J. Biol. Chem. 275, 21278–21286 (2000).
  Article CAS PubMed Google Scholar
• Ling, L., Cao, Z. D. & Goeddel, D. V. NF-κB-inducing kinase activates IKK-α by phosphorylation of ser-176. Proc. Natl Acad. Sci. USA 95, 3792–3797 (1998).An introduction to the biological role of NIK as an activator of IKKα.
  Article CAS PubMed PubMed Central Google Scholar
• Nakano, H. et al. Differential regulation of I-κB kinase-α and -β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase ERK kinase kinase. Proc. Natl Acad. Sci. USA 95, 3537–3542 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, C. et al. NF-κB-inducing kinase is dispensable for activation of NF-κB in inflammatory settings but essential for lymphotoxin-β receptor activation of NF-κB in primary human fibroblasts. J. Immunol. 167, 5895–5903 (2001).
  Article CAS PubMed Google Scholar
• Perkins, N. D. et al. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523–527 (1997).
  Article CAS PubMed Google Scholar
• Shattuck-Brandt, R. L. & Richmond, A. Enhanced degradation of I-κB-α contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res. 57, 3032–3039 (1997).
  CAS PubMed Google Scholar
• Shattuck, R. L., Wood, L. D., Jaffe, G. J. & Richmond, A. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Mol. Cell. Biol. 14, 791–802 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Wood, L. D., Farmer, A. A. & Richmond, A. HMGI (Y), and SP1 in addition to NF-κB regulate transcription of the MGSA/GROα gene. Nucleic Acids Res. 23, 4210–4219 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Wood, L. D. & Richmond, A. Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GROα gene requires both NF-κB and novel constitutive factors. J. Biol. Chem. 270, 30619–30626 (1995).
  Article CAS PubMed Google Scholar
• Kondo, S., Kono, T., Sauder, D. N. & McKenzie, R. C. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J. Invest. Dermatol. 101, 690–694 (1993).
  Article CAS PubMed Google Scholar
• Wang, Y. & Becker, D. Antisense targeting of bFGF and FGF receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nature Med. 3, 887–893 (1997).
  Article CAS PubMed Google Scholar
• Shih, I.-M. & Herlyn, M. Autocrine and paracrine roles for growth factors in melanoma. In Vivo 8, 113–123 (1994).
  CAS PubMed Google Scholar
• Gilmore, T. D., Koedood, M., Piffat, K. A. & White, D. W. Rel/NF-κB/IκB proteins and cancer. Oncogene 13, 1367–1378 (1996).
  CAS PubMed Google Scholar
• Karin, M. & Lin, A. NF-κB at the crossroads of life and death. Nature Immunol. 3, 221–227 (2002).This article provides an up-to-date view of the role of NF-κB activation in the modulation of factors that are involved in apoptosis and cell survival.
  Article CAS Google Scholar
• Dejardin, E. et al. Highly expressed p100/p52 (NF-κB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11, 1835–1841 (1995).
  CAS PubMed Google Scholar
• Tamatani, T. et al. Enhanced IκB kinase activity is responsible for the augmented activity of NF-κB in human head and neck carcinoma cells. Cancer Lett. 171, 165–172 (2001).
  Article CAS PubMed Google Scholar
• Mukhopadhyay, T., Roth, J. A. & Maxwell, S. A. Altered expression of the p50 subunit of the NF-κB transcription factor complex in non-small cell lung carcinoma. Oncogene 11, 999–1003 (1995).
  CAS PubMed Google Scholar
• Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M. P. & Castronov, V. The NF-κB transcription factor and cancer: high expression of NF-κB and IκB-related proteins in tumor cell lines. Biochem. Pharmacol. 47, 145–149 (1994).
  Article CAS PubMed Google Scholar
• Budunova, I. V. et al. Increased expression of p50–NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis. Oncogene 18, 7423–7431 (1999).
  Article CAS PubMed Google Scholar
• Visconti, R. et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression. Oncogene 15, 1987–1994 (1997).
  Article CAS PubMed Google Scholar
• Sovak, M. A. et al. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100, 2952–2960 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Devalaraja, M., Wang, D. Z., Ballard D. W. & Richmond, A. Elevated constitutive IKK activity and IκB-α phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GROα transcription. Cancer Res. 59, 1372–1377 (1999).
  CAS PubMed Google Scholar
• Dhawan, P. & Richmond, A. The role of endogenous NIK and MEKK1 in the constitutive activation of NF-κB in human melanomas. J. Biol. Chem. 277, 7920–7928 (2002).This study shows that, in human melanoma, there is constitutive activation of NIK, and that blocking NIK blocks the constitutive activation of NF-κB in melanoma cells. Moreover, this NIK-mediated effect on NF-κB activity requires the activation of MEKK1 and ERK1/ERK2.
  Article CAS PubMed Google Scholar
• Cusack, J., Liu, R. & Baldwin, A. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-κB activation. Cancer Res. 60, 2323–2330 (2000).
  CAS PubMed Google Scholar
• Budunova, I. V. et al. Increased expression of p50–NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis. Oncogene 19, 3003–3012 (2000).
  Article CAS Google Scholar
• Mayo, M. W. & Baldwin, A. S. The transcription factor NF-κB, control of oncogenesis and cancer-therapy resistance. Biochim. Biophys. Acta 1470, M55–M62 (2000).
  CAS PubMed Google Scholar
• Malinin, N. L., Boldin, M. P., Kovalenko, A. V. & Wallach, D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540–544 (1997).
  Article CAS PubMed Google Scholar
• Xiao, G., Harhaj, E. W. & Sun, S. C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7, 401–409 (2001).
  Article CAS PubMed Google Scholar
• Cogswell, P. C., Guttridge, D. C., Funkhouse, W. K. & Baldwin, A. S. Jr. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene 19, 1123–1131 (2000).
  Article CAS PubMed Google Scholar
• Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495–1499 (2001).
  Article CAS PubMed Google Scholar
• Fagarasan, S. et al. Alymphophasia (aly)-type nuclear factor-κB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J. Exp. Med. 191, 1477–1486 (2000).This article shows that loss of NIK not only affects signalling through the lymphotoxin-β receptor, but also alters the response to chemokines, which indicates that chemokine receptors might also activate NIK.
  Article CAS PubMed PubMed Central Google Scholar
• Zhong, H., Voll, R. E. & Ghosh, S. Rearranged NF-κB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. Mol. Cell 1, 661–671 (1998).
  Article CAS PubMed Google Scholar
• Bird, T. A., Schooley, K., Dower, S. K., Hagen, H. & Virca, G. D. Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein-kinase-II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272, 32606–32612 (1997).
  Article CAS PubMed Google Scholar
• Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T. & Toriumi, W. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353–30356 (1999).
  Article CAS PubMed Google Scholar
• Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H. & Stark, G. R. Distinct roles of the IκB kinase α- and β-subunits in liberating nuclear factor-κB (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J. Biol. Chem. 277, 3863–3869 (2002).This article shows the role of AKT in the activation of IKKα, which potentially phosphorylates the p65 subunit of NF-κB to potentiate its transactivating capacity.
  Article CAS PubMed Google Scholar
• Li, X. & Stark, G. R. NF-κB-dependent signaling pathways. Exp. Hematol. 30, 285–296 (2002).
  Article CAS PubMed Google Scholar
• Delhase, M., Li, N. & Karin, M. Kinase regulation in inflammatory response. Nature 406, 367–368 (2000).
  Article CAS PubMed Google Scholar
• Koul, D., Yao, Y., Abbruzzese, J. L., Yung, W. K. & Reddy, S. A. Tumor suppressor MMAC/PTEN inhibits cytokine induced NF-κB activation without interfering with the IκB degradation pathway. J. Biol. Chem. 276, 11402–11408 (2001).
  Article CAS PubMed Google Scholar
• Madrid, L. V., Mayo, M. W., Reuther, J. Y. & Baldwin, A. S. Jr. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276, 18934–18940 (2001).
  Article CAS PubMed Google Scholar
• Celebi, J. T., Shendrik, I., Silvers, D. N. & Peacocke, M. Identification of PTEN mutations in metastatic melanoma specimens. J. Med. Genet. 37, 653–657 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X. P. et al. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am. J. Pathol. 157, 1123–1128 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Mayo, M. W. et al. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812–1815 (1997).
  Article CAS PubMed Google Scholar
• Finco, T. S. et al. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272, 24113–24116 (1997).
  Article CAS PubMed Google Scholar
• Norris, J. L. & Baldwin, A. S. Oncogenic Ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 274, 13841–13846 (1999).
  Article CAS PubMed Google Scholar
• Troppmair, J., Hartkamp, J. & Rapp, U. R. Activation of NF-κB by oncogenic Raf in HEK293 cells occurs through autocrine recruitment of the stress kinase cascade. Oncogene 17, 685–690 (1998).
  Article CAS PubMed Google Scholar
• Yin, M. J. et al. HTLV-1 Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell 93, 875–884 (1998).
  Article CAS PubMed Google Scholar
• Chu, Z., DiDonato, J., Hawiger, J. & Ballard, D. The tax oncogene of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ. J. Biol. Chem. 273, 15891–15894 (1998).
  Article CAS PubMed Google Scholar
• Geleziunas, R. et al. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase-α (IKKα) and IKKβ cellular kinases. Mol. Cell. Biol. 18, 5157–5165 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Mosialos, G. The role of Rel/NF-κB proteins in viral oncogenesis and the regulation of viral transcription. Semin. Cancer Biol. 8, 121–129 (1997).
  Article CAS PubMed Google Scholar
• LaPorta, C. A. & Camolli, R. PKC-dependent modulation of IκBα–NF-κB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells. Anticancer Res. 18, 2591–2597 (1998).
  CAS Google Scholar
• Biswas, D. K et al. The nuclear factor-κB (NF-κB): a potential therapeutic target for estrogen receptor-negative breast cancers. Proc. Natl Acad. Sci. USA 98, 10386–10391 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wilson, L., Szabo, C. & Salzman, A. L. Protein kinase-C-dependent activation of NF-κB in enterocytes is independent of IκB degradation. Gastroenterology 117, 106–114 (1999).
  Article CAS PubMed Google Scholar
• Han, Y., Meng, T., Murray, N. R., Fields, A. P. & Brasier, A. R. Interleukin-1-induced nuclear factor-κB–IκB-α autoregulatory feedback loop in hepatocytes. A role for protein kinase Cα in post-transcriptional regulation of IκB-α resynthesis. J. Biol. Chem. 274, 939–947 (1999).
  Article CAS PubMed Google Scholar
• Anrather, J., Csizmadia, V., Soares, M. P. & Winkler, H. Regulation of NF-κB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Cζ in primary endothelial cells. J. Biol. Chem. 274, 13594–13603 (1999).
  Article CAS PubMed Google Scholar
• Wang, D. & Richmond, A. NF-κB activation by the CXC-chemokine MGSA/GROα involves the MEKK1/p38 MAP kinase pathway. J. Biol. Chem. 276, 3650–3659 (2001).
  Article CAS PubMed Google Scholar
• Richmond, A. & Thomas, H. G. Melanoma growth stimulatory activity, a novel growth factor with a tissue distribution not restricted to melanoma tissue. J. Cell. Biochem. 36, 185–198 (1988).
  Article CAS PubMed Google Scholar
• Singh, R. K. et al. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 54, 3242–3247 (1994).
  CAS PubMed Google Scholar
• Singh, R. K. et al. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin-8. Cancer Res. 55, 3669–3674 (1995).
  CAS PubMed Google Scholar
• Schadendorf, D. et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151, 2667–2675 (1993).
  CAS PubMed Google Scholar
• Schadendorf, D. et al. Metastatic potential of human melanoma cells in nude mice — characterization of phenotype, cytokine secretion and tumor-associated antigens. Br. J. Cancer 74, 194–199 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Loukinova, E. et al. Growth-regulated oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC-receptor-2-dependent mechanism. Oncogene 19, 3477–3486 (2000).
  Article CAS PubMed Google Scholar
• Matsusaka, T. et al. Transcription factors NF-IL-6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin-6 and interleukin-8. Proc. Natl Acad. Sci. USA 90, 10193–10197 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Balentien, E. et al. Effects of MGSA/GROα on melanocyte transformation. Oncogene 6, 1115–1124 (1991).
  CAS PubMed Google Scholar
• Nirodi, C. S. & Richmond, A. Role of poly (ADP-ribose) polymerase (PARP) in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene. J. Biol. Chem. 276, 9366–9374 (2001).This article shows that PARP participates with NF-κB in the modulation of transcription of CXCL1.
  Article CAS PubMed Google Scholar
• Nirodi, C. S. et al. The 170-kDa CCAAT displacement protein (CDP/Cut) selectively binds the IUR _cis_-element in the CXCL1 promoter. The role of CDP in the negative regulation of CXCL1 gene expression. J. Biol. Chem. 276, 9366–9374 (2001).This study further defines the CXCL1 enhanceosome and shows that binding of the transcriptional repressor CDP to an element adjacent to the NF-κB-binding site represses the transcription of CXCL1.
  Article CAS PubMed Google Scholar
• Hassa, P. O. & Hottiger, M. O. A role of poly (ADP-ribose) polymerase in NF-κB transcriptional activation. Biol. Chem. 380, 953–959 (1999).
  Article CAS PubMed Google Scholar
• Ludlow, C., Choy, R. & Blochlinger, K. Functional analysis of Drosophila and mammalian Cut proteins in flies. Dev. Biol. 178, 149–159 (1996).
  Article CAS PubMed Google Scholar
• Coqueret, O., Berube, G. & Nepveu, A. The mammalian Cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase. EMBO J. 17, 4680–4694 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Mailly, F. G. et al. The human Cut homeodomain protein can repress gene expression by two distinct mechanisms: active repression and competition for binding-site occupancy. Mol. Cell. Biol. 16, 5346–5357 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Li, S. et al. Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/Cut homolog, is associated with histone deacetylation. J. Biol. Chem. 274, 7803–7815 (1999)
  Article CAS PubMed Google Scholar
• Li, S., Aufiero, B., Schiltz, R. L. & Walsh, M. J. Regulation of the homeodomain CCAAT displacement/Cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP. Proc. Natl Acad. Sci. USA 97, 7166–7171 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Xiao, H., Hasegawa, T. & Isobe, K. p300 collaborates with Sp1 and Sp3 in p21(Waf1/Cip1) promoter activation induced by histone deacetylase inhibitor. J. Biol. Chem. 275, 1371–1376 (2000).
  Article CAS PubMed Google Scholar
• Kundu, T. K. et al. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell. 6, 551–561 (2000).This article shows the role of p300 in acetylation of histones and the stabilization of the transcriptional machinery.
  Article CAS PubMed Google Scholar
• Bottazzi, B., Walter, S., Govoni, D., Colotta, F. & Mantovani, A. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth and susceptibility to IL-2 therapy of murine melanoma. J. Immunol. 148, 1280–1285 (1992).
  CAS PubMed Google Scholar
• Nakashima, E. et al. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo. Pharm. Res. 12, 1598–1604 (1995).
  Article CAS PubMed Google Scholar
• Berman, K. S. et al. Sulindac enhances tumor necrosis factor-α-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-κB. Clin. Cancer Res. 8, 354–360 (2002).
  CAS PubMed Google Scholar
• May, M. J. et al. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289, 1550–1554 (2000).
  Article CAS PubMed Google Scholar
• Yamamoto, Y. & Gaynor, R. B. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107, 135–142 (2001).This article emphasizes the available data that indicate that, by developing methods of disrupting the NF-κB pathway, new advances can be made in the therapeutic intervention of acute and chronic inflammatory conditions, as well as malignancies.
  Article CAS PubMed PubMed Central Google Scholar
• Hideshima, T. et al. NF-κB as a therapeutic target in multiple myeloma. J. Biol. Chem. 277, 16639–16647 (2002).
  Article CAS PubMed Google Scholar
• Tan, C. & Waldmann, T. A. Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia. Cancer Res. 62, 1083–1086 (2002).
  CAS PubMed Google Scholar
• Adams, J. Proteasome inhibition, a novel approach to cancer therapy. Trends Mol. Med. 8, 49–54 (2002).This article reviews the current status of the use of proteasome inhibitors to block tumour growth.
  Article Google Scholar
• Zhang, J., Chang, C. C., Lombardi, L., Dalla-Favera, R. Rearranged NF-κB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. Oncogene 9, 1931–1937 (1994).
  CAS PubMed Google Scholar
• Higgins, K. A. et al. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl Acad. Sci. USA 90, 9901–9905 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Shah, S. A. et al. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J. Cell. Biochem. 82, 110–122 (2001).
  Article CAS PubMed Google Scholar
• Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P. & Aggarwal, B. B. Curcumin downregulates cell-survival mechanisms in human prostate cancer cell lines. Oncogene 20, 7597–7609 (2001).
  Article CAS PubMed Google Scholar
• Nourbakhsh, M. et al. The NF-κB repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-κB-flanking sequence element. J. Biol. Chem. 276, 4501–4508 (2001).This article models the components of the enhanceosome for CXCL8 and shows that a transcriptional repressor binds to an element flanking the NF-κB element. So, the models for the transcription of CXCL8, CXCL1 and IL-6 are similar.
  Article CAS PubMed Google Scholar
• Stein, B., Cogswell, P. S. & Baldwin, A. S. Functional and physical associations between NF-κB and C/EBP family members: a Rel domain–bZIP interaction. Mol. Cell Biol. 13, 3964–3974 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Li, S., Aufiero, B., Schiltz, R. L. & Walsh, M. J. Regulation of the homeodomain CCAAT displacement/Cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP. Proc. Natl Acad. Sci. USA 97, 7166–7171 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Chemokine/chemokine receptor nomenclature. International Union of Immunological Societies/World Health Organization Subcommittee on Chemokine Nomenclature. J. Leukoc Biol. 70, 465–466 (2001). ||Pubmed